Nektar Therapeutics
NKTR
NKTR
237 hedge funds and large institutions have $2.88B invested in Nektar Therapeutics in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 74 increasing their positions, 78 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less call options, than puts
Call options by funds: $11.1M | Put options by funds: $11.8M
15% less capital invested
Capital invested by funds: $3.39B → $2.88B (-$509M)
Holders
237
Holding in Top 10
–
Calls
$11.1M
Puts
$11.8M
Top Buyers
| 1 | +$25.7M | |
| 2 | +$11.3M | |
| 3 | +$8.04M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.33M |
| 5 |
Two Sigma Investments
New York
|
+$5.18M |
Top Sellers
| 1 | -$34.1M | |
| 2 | -$28.8M | |
| 3 | -$15.3M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$7.63M |
| 5 |
BlackRock
New York
|
-$7.39M |